title: Prognosis of renal amyloidosis: a clinicopathological study using cluster analysis.
abstract: Progression of renal amyloidosis is associated with severe proteinuria or nephrotic syndrome, and various mechanisms have been postulated to explain these complications. We studied the acceleration of proteinuria and reduced renal function by cluster analysis using clinical parameters, renal histological findings, type of renal amyloidosis and follow-up data. We divided 97 cases into three groups of renal amyloidosis. Accelerated progression correlated with serum creatinine (s-Cr) levels at renal biopsy and histological grade of renal damage by amyloid deposition (p < 0.0001). The most influential prognostic factors (s-Cr level > or =2.0 mg/dl) were tubulointerstitial and vascular damage induced by amyloid deposition at biopsy (odds ratio 96.9 and 69.2, respectively). In addition, we found amyloidosis type amyloid associated (AA) correlated with more amyloid-mediated vascular and tubulointerstitial damage than amyloidosis type amyloid light chain (AL) (p < 0.001, p < 0.01, respectively). Proteinuria and nephrotic syndrome were more severe in cases of amyloidosis AL than in amyloidosis AA (p = 0.076). In conclusion, less tubulointerstitial and vascular damage was caused by amyloid deposition; this was slowly progressive. Amyloid AA was detected in tubulointerstitial tissue and vessels more frequently than amyloid AL. Heavy proteinuria and/or nephrosis were not indicators of rapid progression.
authors.affiliation: Second Department of Pathology, School of Medicine, Fukuoka University, 45-1 Nanakuma 7-chome, Jonan-ku, Fukuoka 814-0133, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Sasatomi
authors.forename: Y
authors.initials: Y
authors.lastname: Kiyoshi
authors.forename: N
authors.initials: N
authors.lastname: Uesugi
authors.forename: S
authors.initials: S
authors.lastname: Hisano
authors.forename: S
authors.initials: S
authors.lastname: Takebayashi
mesh_terms: D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000401:mortality / Q000473:pathology*; D001706:Biopsy; D016000:Cluster Analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007674:Kidney Diseases / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D015996:Survival Rate